COMMUNIQUÉS West-GlobeNewswire

Dyadic Announces Continued Listing on the Nasdaq Capital Market
24/07/2026
JUPITER, Fla., July 24, 2026 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (Nasdaq: DYAI) (“Dyadic” or the “Company”), d/b/a Dyadic Applied BioSolutions, a biotechnology company developing recombinant protein solutions [...]
Zevra Therapeutics Provides Update on Regulatory Submission for Arimoclomol for the Treatment of Niemann-Pick Disease Type C (NPC) in the European Union
24/07/2026
Company plans to request re-examination following negative CHMP opinion for arimoclomol MAA Zevra continues to support access to arimoclomol for eligible patients through its global Expanded Access Program BOSTON, July [...]
BiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe
24/07/2026
Collaboration expands Zorronet's AI-powered detection, analysis and response capabilities into agricultural security, theft and critical transportation infrastructure protection NETANYA, Israel, July 24, 2026 (GLOBE [...]
Ondra Health Names Every Pharmacy That Fills Its GLP-1 Prescriptions, a Disclosure Most Telehealth Platforms Don't Make
24/07/2026
Patients are told to verify their provider before starting GLP-1 treatment. The Los Angeles-based platform publishes its five licensed compounding pharmacies, the prescribing medical group, and full pricing so that [...]
Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026
24/07/2026
SYDNEY, AUSTRALIA, July 24, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announced [...]
Amwell® to report second quarter 2026 operating results
24/07/2026
BOSTON, July 24, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2026 operating results [...]
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
24/07/2026
- Positive CHMP opinion supports potential commercialization of obicetrapib monotherapy and obicetrapib/ezetimibe fixed-dose combination in Europe - - Recommendation based on positive Phase 3 BROADWAY, BROOKLYN, and [...]
Magnendo Secures $18M Series A Financing to Transform Endovascular Access for Stroke Intervention
24/07/2026
MIT spinout to accelerate product development and first-in-human studies of its magnetic robotic navigation platform designed to dramatically improve the speed and reliability of neuro-endovascular procedures NEWTON, [...]
Autonomix Medical Demonstrates Renal Nerve Sensing and Neural Activity Change in Preclinical Study
24/07/2026
Data demonstrate the ability to detect, localize and confirm changes in renal neural activity, supporting continued development of physiology-guided renal denervation THE WOODLANDS, TX, July 24, 2026 (GLOBE NEWSWIRE [...]
NEZGLYAL® (leriglitazone) receives a positive CHMP opinion for the treatment of cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease
24/07/2026
Recommendation based on NEXUS data; Minoryx and Neuraxpharm expect European Commission approval by the end of this quarter BARCELONA, Spain and DÜSSELDORF, Germany, July 24, 2026 (GLOBE NEWSWIRE) -- Minoryx Therapeutics [...]
hear.com Honored as Gold Stevie® Award Winner in 2026 Stevie Awards for Technology Excellence
24/07/2026
Award recognizes Horizon IX hearing aids and Clinic-in-a-Box® tele-audiology for expanding access to hearing care nationwide MIAMI, July 24, 2026 (GLOBE NEWSWIRE) -- hear.com , a global innovator in hearing care, has [...]
Surgery Partners Announces Entry Into Agreement to Sell Ownership Interests in Idaho Falls Facilities to Intermountain Health; Reaffirms Guidance, Excluding Impact of Transaction
24/07/2026
Represents significant milestone in the Company’s ongoing portfolio optimization efforts BRENTWOOD, Tenn., July 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a [...]
Ernexa Therapeutics CEO Corner Emphasizes How ERNA-101 Could Help Unlock the Next Generation of Combination Cancer Therapies
24/07/2026
CEO Discusses Why the Future of Cancer Treatment May Belong to Combination Approaches and How ERNA-101 Was Designed to Turn Immunologically "Cold" Tumors Into Targets for the Immune System Video Showcases Differentiated [...]
Dr. Ekta Pandya Named Fellow of Pierre Fauchard Academy, Recognized for Leadership in Dentistry and Children's Oral Health
24/07/2026
Pierre Fauchard Academy Fellow recognized for leadership in dentistry, education, pediatric oral health, and community service Dr. Ekta Pandya, newly named Pierre Fauchard Academy Fellow. NEW PALTZ, N.Y., July 24, 2026 [...]
Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial
24/07/2026
– Whole-gland TULSA ablation demonstrates statistically significant superior penile length preservation compared to robotic RP at 1 month – TORONTO, July 24, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF [...]
Serina Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
24/07/2026
HUNTSVILLE, Ala., July 24, 2026 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina” or the “Company”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug [...]
CHMP recommends EU approval of Roche’s Susvimo, the first continuous delivery treatment for neovascular age-related macular degeneration (nAMD)
24/07/2026
Susvimo is the first and only continuous delivery treatment that offers an alternative to standard of care eye injections for nAMD Positive recommendation is based on data from the LADDER, Archway and Portal studies [...]
MannKind Announces FDA Approval of Furoscix ReadyFlow™, the First and Only Autoinjector Delivering IV-Equivalent Diuretic Therapy for the Treatment of Edema in Adults with Heart Failure or Chronic Kidney Disease
24/07/2026
Transformative delivery option that may support earlier management of worsening fluid overload with a self-administered option designed for use outside the hospital setting Delivers IV-equivalent diuretic effect through [...]
MannKind Announces $50 Million Private Placement
24/07/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., July 24, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient [...]

Pages